AKT1 and pituitary adenocarcinoma: Furthermore, COL6A6 was reported to inhibit the PI3K-Akt pathway; Long et al. found that COL6A6 suppressed the growth and metastasis of pituitary adenocarcinoma by blocking the PI3K-Akt pathway (11).